Identity
HGNC
LOCATION
8p22
LOCUSID
ALIAS
ATRC2,CAT2,HCAT2
FUSION GENES
Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 6542
MIM: 601872
HGNC: 11060
Ensembl: ENSG00000003989
Variants:
dbSNP: 6542
ClinVar: 6542
TCGA: ENSG00000003989
COSMIC: SLC7A2
RNA/Proteins
Expression (GTEx)
Pathways
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 38419038 | 2024 | Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington's disease. | 0 |
| 38842202 | 2024 | SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer. | 0 |
| 38419038 | 2024 | Elevated SLC7A2 expression is associated with an abnormal neuroinflammatory response and nitrosative stress in Huntington's disease. | 0 |
| 38842202 | 2024 | SLC7A2-Mediated Lysine Catabolism Inhibits Immunosuppression in Triple Negative Breast Cancer. | 0 |
| 36639771 | 2023 | Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. | 4 |
| 38203268 | 2023 | Integrated Amino Acids and Transcriptome Analysis Reveals Arginine Transporter SLC7A2 Is a Novel Regulator of Myogenic Differentiation. | 0 |
| 36639771 | 2023 | Lower SLC7A2 expression is associated with enhanced multidrug resistance, less immune infiltrates and worse prognosis of NSCLC. | 4 |
| 38203268 | 2023 | Integrated Amino Acids and Transcriptome Analysis Reveals Arginine Transporter SLC7A2 Is a Novel Regulator of Myogenic Differentiation. | 0 |
| 34108444 | 2021 | SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells. | 17 |
| 34108444 | 2021 | SLC7A2 deficiency promotes hepatocellular carcinoma progression by enhancing recruitment of myeloid-derived suppressors cells. | 17 |
| 32008093 | 2020 | Human cationic amino acid transporters are not affected by direct nitros(yl)ation. | 1 |
| 32647070 | 2020 | SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer. | 15 |
| 32008093 | 2020 | Human cationic amino acid transporters are not affected by direct nitros(yl)ation. | 1 |
| 32647070 | 2020 | SLC7A2 serves as a potential biomarker and therapeutic target for ovarian cancer. | 15 |
| 28501704 | 2017 | Genetic variation in SLC7A2 interacts with calcium and magnesium intakes in modulating the risk of colorectal polyps. | 5 |
Citation
Dessen P
SLC7A2 (solute carrier family 7 member 2)
Atlas Genet Cytogenet Oncol Haematol. 2016-10-01
Online version: http://atlasgeneticsoncology.org/gene/56383/slc7a2-(solute-carrier-family-7-member-2)
